- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 10-K Annual report
- 3.1 Exhibit 3.1 Articles of Incorporation
- 3.1.1 Exhibit 3.1.1 Articles of Merger
- 3.2.1 Exhibit 3.2.1 Bylaws Amendments
- 10.1 Exhibit 10.1 2009 Stock Incentive Plan
- 10.3 Exhibit 10.3 Exclusive License Agreement
- 10.4 Exhibit 10.4 Investor Relations Caa
- 10.5 Exhibit 10.5 Employment Agreement
- 10.6 Exhibit 10.6 Employment Agreement
- 23.1 Exhibit 23.1 Consent of Independent Acct Firm
- 31.1 Exhibit 31.1 Section 302 Certification
- 31.2 Exhibit 31.2 Section 302 Certification
- 32.1 Exhibit 32.1 Section 906 Certification
Exhibit 32.1
SARBANES-OXLEY SECTION 906 CERTIFICATION
In connection with the Annual Report on Form 10-K of Therapeutic Solutions International, Inc. (the "Company") for the year ending December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Dixon, Chief Executive Officer and President of the Company, and I, Gerry Berg, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 30, 2012
By: /s/ Timothy G. Dixon
Timothy G. Dixon
Chief Executive Officer and President
(Principal Executive Officer)
By: /s/ Gerry Berg
Gerry Berg
Chief Financial Officer
(Principal Financial Officer)